Zika, chikungunya and dengue: the causes and threats of new and re-emerging arboviral diseases

ES Paixão, MG Teixeira, LC Rodrigues - BMJ global health, 2018 - gh.bmj.com
The recent emergence and re-emergence of viral infections transmitted by vectors—Zika,
chikungunya, dengue, Japanese encephalitis, West Nile, yellow fever and others—is a …

History, epidemiology, and clinical manifestations of Zika: a systematic review

ES Paixão, F Barreto… - … journal of public …, 2016 - ajph.aphapublications.org
Objectives. To describe salient epidemiological characteristics of Zika virus outbreaks
across the world and to examine the clinical presentations, complications, and atypical …

Dengue during pregnancy and adverse fetal outcomes: a systematic review and meta-analysis

ES Paixão, MG Teixeira… - The Lancet infectious …, 2016 - thelancet.com
Background Little is known about the possible adverse effects of dengue infection during
pregnancy on fetal outcomes. In this systematic review and meta-analysis we aimed to …

[HTML][HTML] Vaccine effectiveness of heterologous CoronaVac plus BNT162b2 in Brazil

T Cerqueira-Silva, SV Katikireddi… - Nature Medicine, 2022 - nature.com
There is considerable interest in the waning of effectiveness of coronavirus disease 2019
(COVID-19) vaccines and vaccine effectiveness (VE) of booster doses. Using linked national …

[HTML][HTML] Vaccine effectiveness of CoronaVac against COVID-19 among children in Brazil during the Omicron period

PTV Florentino, FJO Alves, T Cerqueira-Silva… - Nature …, 2022 - nature.com
Although severe COVID-19 in children is rare, they may develop multisystem inflammatory
syndrome, long-COVID and downstream effects of COVID-19, including social isolation and …

[HTML][HTML] Vaccine effectiveness of two-dose BNT162b2 against symptomatic and severe COVID-19 among adolescents in Brazil and Scotland over time: a test-negative …

PTV Florentino, T Millington… - The Lancet Infectious …, 2022 - thelancet.com
Background Little is known about vaccine effectiveness over time among adolescents,
especially against the SARS-CoV-2 omicron (B. 1.1. 529) variant. This study assessed the …

Vaccination plus previous infection: protection during the omicron wave in Brazil

T Cerqueira-Silva, V de Araujo Oliveira… - The Lancet Infectious …, 2022 - thelancet.com
As of May 11, 2022, an estimated 519 million individuals have been infected with SARS-
CoV-2, and at least 11 billion COVID-19 vaccine doses were positive and defined as cases …

Effectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26. COV2. S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative …

T Cerqueira-Silva, JR Andrews… - The Lancet Infectious …, 2022 - thelancet.com
Background COVID-19 vaccines have proven highly effective among individuals without a
previous SARS-CoV-2 infection, but their effectiveness in preventing symptomatic infection …

Chikungunya chronic disease: a systematic review and meta-analysis

ES Paixão, LC Rodrigues, MCN Costa… - Transactions of The …, 2018 - academic.oup.com
Background Chikungunya is a mosquito-borne disease caused by an arthritogenic
alphavirus, with four genotypes: East Central South African (ECSA), West African, ECSA …

[HTML][HTML] Duration of protection of CoronaVac plus heterologous BNT162b2 booster in the Omicron period in Brazil

T Cerqueira-Silva, V de Araujo Oliveira… - Nature …, 2022 - nature.com
To date, no information has been published on the effectiveness of inactivated whole-virus
COVID-19 vaccines plus heterologous booster against symptomatic infection and severe …